Skip to content

Contact +44 (0) 20 7060 7474 email us

Biotechnology

Biologic Imaging Reagents

Technologies and Global Markets

Publication Date December 2008
Publisher BCC Research
Product Type Report
Pages 242
ISBN Number not applicable
Product Code BCC00086

Price

£3,205.00
approximately: $4,853 | €3,577

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

This report:

  • Describes various imaging reagent types including optical probes and dyes, imaging nanomaterials, supermolecules, contrast agents and radiopharmaceuticals
  • Provides market forecasts to determine the global market and future demand growth for biologic imaging reagents over a 5-year period, from 2008 to 2013
  • Evaluates future growth opportunities in imaging reagents for life science companies
  • Provides a comprehensive discussion of where state-of-the-art is in biologic imaging reagents and forecasts the future market potential for key market segments
  • Includes company profiles and industry alliances.

Study Goals And Objectives

BCC's goal for this study is to determine the global market and future demand growth for biologic imaging reagents over a five-year period from 2008 to 2013. Our particular interest is to characterize and quantify the biologic imaging reagents market potential by technology, reagent type and end user market. We also evaluate future growth opportunities in emerging biologic imaging reagents such as quantum dots, nanoparticles, fluorescent proteins and supermolecules.

Imaging reagent types covered include fluorescent probes and dyes; fluorescent proteins; nanoparticles; fullerene and dendrimer supermolecules; magnetic resonance imaging; ultrasound and x-ray contrast reagents; and imaging radiopharmaceuticals.

Our key objective is to present a comprehensive discussion of where the state-of-the-art is in biologic imaging reagents and forecast the future commercial potential for the key market segments. This discussion will provide a basis for companies to make strategic choices about developing new products and markets, or employing biologic imaging reagents. The study will benefit reagent and instrument manufacturers; users of biologic imaging reagents; medical instrument companies; life sciences tools companies; diagnostic and drug manufacturers; biotechnology companies; and developers of nanotechnologies.

Reasons For Doing The Study

Biologic imaging reagents play an important role in the medical, pharmaceutical, diagnostic, biotechnology and life sciences tools industries. Imaging and detection technologies are used extensively in medicine, biotechnology and pharmaceutical research. Traditional imaging techniques, such as x-ray, computer tomography (CT), ultrasound (US), magnetic resonance imaging (MRI) and nuclear medicine (NM), mainly analyze anatomy and morphology and cannot detect changes at the molecular level. However, new developments in biotechnology allow us to image at the cellular and molecular level, paving the way for earlier diagnosis and treatment of disease. Biologic imaging reagents play a critical role in this medical revolution.

At the same time, tremendous advances in genomics, proteomics and cellular analysis are assisted by imaging technologies including fluorescent dyes and probes, quantum dot nanoparticles, and fluorescent proteins. Growth in technologies such as biochips, DNA sequencing, and PCR relies on sensitive biologic fluorescent imaging reagents.

Advances in technologies that are used in biologic imaging reagents are also moving forward at a rapid pace. These technologies include nanotechnology, biologic targeting, microfluidics, supramolecular chemistry and protein engineering. Rapid developments across a number of technology fields promise to change the biologic imaging industry by enabling novel imaging reagents and unique market opportunities. This report analyzes these developments and their impact on the future markets for biologic imaging reagents.

Given these market and technology dynamics, it is especially timely to examine the biologic imaging reagents market.

Intended Audience

We have compiled a study of existing and future imaging reagent technologies that will be commercially important in the major end user segments including life science research tools, drug discovery & development, and diagnostics.

We present the various imaging reagent technologies, including fluorescent probes and dyes; nanomaterials; fluorescent proteins; supermolecules; contrast reagents, and imaging radiopharmaceuticals. We also examine the industry growth driving forces; product types; market applications; companies and industry alliances and acquisitions; future market potential and product sales forecasts for the period 2008 through 2013. We project the future use of biologic imaging reagents in the main end user segments and by technology.

This study will be of particular interest to life science research tools suppliers, pharmaceutical manufacturers, diagnostics, biotechnology, genomics, proteomics, nanotechnology and supramolecular companies. It will also be of interest to companies making products for medical imaging, microarrays, lab on a chip, polymerase chain reaction (PCR), molecular diagnostics assays, fluorescence in-situ hybridization (FISH), fluorescence activated cell sorting (FACS) as well as medical researchers and clinicians.

Scope Of Report

The study scope includes the biologic imaging reagents that are commercial or likely to be commercialized within the next five years. Fluorescent probes and dyes, imaging nanomaterials (including quantum dots and other nanoparticles), fluorescent proteins; supermolecules; contrast reagents for MRI, x-ray and ultrasound, and imaging radiopharmaceuticals are studied. Both the in-vivo and in-vitro market segments are included. Each technology is analyzed to determine its market status, impact on future market segments, and forecasted growth from 2008 through 2013. Technology status and market driving forces are also discussed.

BCC examines imaging reagent producers and the industry structure in specialized segments of the industry. We also review industry alliances and acquisitions, and the use of biologic imaging reagents in key diagnostics and R&D tools platforms including microarrays, lab-on-a-chip devices, DNA sequencing, PCR and cellular analysis. The markets for novel biologic imaging reagent applications, including targeted multifunctional and hybrid therapeutic reagents are analyzed, and the main companies in these fields are highlighted.

Methodology

BCC surveyed key users and producers in each of the end user market segments and technology fields that will be commercially important during the next five years. Discussions with industry thought leaders, as well as secondary market research was performed.

Based on our analysis, we project the future applications of biologic imaging reagents in the major end user market segments and by technology type, and forecast sales revenues for 2008 through 2013.

Information Sources

BCC surveyed academic, government and industrial institutions to obtain data for this study. Included were life science research tools, pharmaceutical, diagnostic, biotechnology and nanotechnology firms, and leading life science research institutions. We also spoke with leading industry thought leaders. In addition, we compiled data from secondary sources including industry, trade, and government.

Contents

  • Chapter One: Introduction
    • Study Goals And Objectives
    • Reasons For Doing The Study
    • Intended Audience
    • Scope Of Report
    • Methodology
    • Information Sources
    • Related Bcc Reports
    • Analyst Credentials
    • Bcc Research Online Services
    • Disclaimer
  • Chapter Two: Summary
    • Summary Table Global Value Of Biologic Imaging Reagents, By Type, Through 2013 ($ Millions)
    • Summary Figure Global Value Of Biologic Imaging Reagents, By Type, 2006-2013 ($ Millions)
  • Chapter Three: Overview
    • Introduction
    • Biologic Imaging Technologies Covered In This Report
    • Table 1 Scope Of This Report Market Potential Of Biologic Reagents Products
    • Table 2 Global Value Of Biologic Imaging Reagents, By Technology, Through 2013 ($ Millions)
    • Table 3 Global Value Of Biologic Imaging Reagents, By End User Market, Through 2013 ($ Millions)
    • Forces Driving Biologic Imaging Reagents Industry Growth
    • Table 4 Biologic Imaging Reagents Growth Driving Forces
    • Life Cycle Status Of Biologic Imaging Reagents Technologies
    • Table 5 Life Cycle Stage Of Biologic Imaging Reagents
    • The Biologic Imaging Reagents Industry
    • Table 6 Biologic Imaging Reagents Key Competitors
  • Chapter Four: Biologic Imaging Technologies
    • Imaging Reagent Types
    • Table 7 Key Biologic Imaging Reagent Types
    • In-Vivo Imaging Modalities
    • Table 8 In-Vivo Imaging Modalities
    • Table 9 Comparison Of In-Vivo Imaging Modalities
    • Molecular Imaging
    • In-Vitro Imaging/Detection
    • Table 10 Applications Of In-Vitro Biologic Imaging
    • Trends In In-Vivo Imaging
    • Table 11 Key Trends For In-Vivo Imaging
    • Trends In In-Vivo Imaging (Continued)
    • Biologic Imaging Reagents Technologies
    • Nanoparticles
    • Table 12 Nanoparticles In Imaging Applications
    • Table 13 Comparison Of Antibody Conjugate Nanoparticles
    • Fluorescent Dyes And Probes
    • Table 14 Fluorescent Dyes And Probes
    • Table 15 Advantages Of Fluorescence Versus
    • Traditional Methods
    • Table 16 Fluorescent Dye Performance Criteria
    • Fluorescent Proteins
    • Table 17 Types Of Fluorescent Proteins
    • Genetically Engineering Fluorescent Proteins
    • Table 18 Photoactivable And Photoconvertible
    • Fluorescent Protein Types
    • Engineered Fluorescent Cell Lines
    • Emerging Fluorescent Protein Applications
    • Table 19 Emerging Applications Of Fluorescent
    • Proteins
    • Comparison Of Fluorescent Proteins With Fluorescent
    • Dyes
    • Table 20 Fluorescent Proteins Versus Dyes
    • Technology Challenges
    • Table 21 Technology Challenges For Fluorescent
    • Proteins
    • Supermolecules
    • Table 22 Classification Of Imaging Supermolecules
    • Figure 1 Molecular Engineering Of Dendrimer Imaging
    • Supermolecules
    • Quantum Dots
    • Table 23 Comparison Of Quantum Dots, Fluorescent
    • Dyes And Fluorescent Proteins
    • Figure 2 Quantum Dot Spectra
    • Figure 3 Fluorescent Dye Spectra
    • Table 24 Biologic Imaging Applications Of Quantum Dots
    • Radiopharmaceuticals
    • Contrast Reagents
    • Emerging Classes Of Imaging Reagents
    • Components Of Advanced Imaging Reagent
    • Technology
    • Figure 4 Three Components Of Advanced Imaging
    • Reagent Technology
    • Advanced Imaging Reagent Functions
    • Table 25 Emerging Advanced Biologic Imaging Reagent
    • Functions
    • Dual Modality Reagents
    • Multifunctional Reagents
    • Multiplexed Reagents
    • Biologic Imaging Reagents Manufacturing Costs
    • Figure 5 Manufacturing Costs Of Imaging Reagent Classes
    • Comparison Of Imaging Reagent Technology
    • Platforms
    • Table 26 Life Cycle Of Biologic Imaging Reagent Technologies
    • Table 27 Technology Status Of Biologic Imaging Reagent Platforms
    • Table 28 Technology Challenges For In-Vivo Imaging Reagents
  • Chapter 5: Biologic Imaging Reagents Applications
    • Overview
    • Table 29 Biologic Imaging Reagents Applications
    • Table 30 Significance Of Biologic Imaging Reagents To
    • Life Sciences And Medical Industries
    • Table 31 Use Of Biologic Imaging Reagents By Market Segment
    • Table 32 Applications Within Market Segments Research And Development
    • Table 33 R&d Tools
    • Table 34 Emerging Applications For Biologic Imaging
    • Reagents In R&d Tools
    • Drug Discovery And Development
    • Table 35 Drug Discovery & Development
    • Influence Of Imaging Technology On Drug
    • Development
    • Attrition Rate Of Lead Compounds
    • Figure 6 Attrition Rate Of Drug Candidates During
    • Drug Development
    • Fluorescent Protein Applications In Drug
    • Discovery
    • In-Vivo Small Animal Imaging Applications
    • Table 36 Comparison Of Small Animal Imaging
    • Modalities
    • Table 37 Outstanding Market Needs For Small Animal
    • Imaging
    • Microdosing
    • Biomarkers For Microdosing
    • Table 38 Biomarkers For Microdosing
    • Regulatory Requirements For Microdosing
    • Imaging Modalities For Microdosing
    • Table 39 Microdosing Imaging Modalities
    • Status Of Microdosing
    • Diagnostics
    • Introduction
    • Table 40 Diagnostics Imaging Reagents Applications
    • Diagnostic Applications Of Imaging Reagents
    • Table 41 Diagnostic Applications Of Selected Imaging
    • Reagents
    • Fluorescent Dyes, Probes And Tags
    • Nanoparticles
    • Supermolecules
    • Imaging Radiopharmaceuticals
    • Contrast Reagents
    • Molecular Imaging
    • Introduction
    • Table 42 Clinical Applications For In Vivo Molecular
    • Imaging
    • Optical Molecular Imaging Reagents Status
    • Table 43 Fluorescence Imaging Reagents Pipeline
    • Status
    • Pet/Spect Molecular Imaging Reagents Status
    • Table 44 Pet/Spect Imaging Reagents Pipeline Status
    • Biological Processes Associated With Molecular Pet
    • Imaging Reagents
    • Table 45 Pet Imaging Reagent Applications
    • Case Study: Alzheimer's Disease Imaging
    • Reagent Opportunities
    • Figure 7 Alzheimer's Disease's Pathology Progression
    • Mr Imaging Reagents
    • Table 46 Existing And Emerging Mri Imaging Reagents Status
    • Ultrasound Imaging Reagents
    • Nanoparticles In Diagnostics
    • Table 47 Nanoparticle In-Vivo Diagnostics Pipeline
    • Table 48 Nanosphere In-Vitro Diagnostics Reagents
    • Pipeline
    • Hybrid Diagnostic/Therapeutic Applications
    • Table 49 Hybrid Imaging/Therapeutic Applications
  • Chapter Six: Biologic Imaging Reagents Industry
    • Structure
    • Medical Imaging Instrument Industry
    • Table 50 Competitive Focus Of Major Medical Imaging
    • Companies
    • Innovation Within The Imaging Reagent Industry
    • Role Of Core Imaging Facilities
    • Role Of Strategic Alliances
    • Table 51 Recent Imaging Reagent Strategic Alliances
    • Table 52 Biologic Imaging Reagents Industry
    • Acquisitions, 2005-2008
    • 2005
    • 2006
    • 2007
    • 2008
    • Specialized Industry Sectors
    • Fluorescent Dyes And Probes
    • Table 53 Fluorescent Dyes And Probes Key Competitors
    • Quantum Dots
    • Table 54 Quantum Dots Key Competitors
    • Table 54 (Continued)
    • Contrast Reagents
    • Table 55 Contrast Reagents Key Competitors
    • Radiopharmaceuticals
    • Table 56 Radiopharmaceuticals Biotechnology
    • Companies
    • Radioactive Isotope Supply Industry
    • Small Animal In-Vivo Imaging
    • Table 57 Small Animal In-Vivo Functional Imaging
    • Competitors
    • Cardiac Imaging
    • Table 58 Cardiac Imaging Reagent Competitive Space
    • Fluorescent Proteins
    • Table 59 Fluorescent Protein Producers
    • Antibody Biotechnology Companies
    • Table 60 Antibody Biotechnology Companies Who Have
    • Interest In Imaging Reagents
  • Chapter Seven: Biologic Imaging Reagents Markets
    • Growth Driving Forces
    • Table 61 Biologic Imaging Reagents Growth Driving
    • Forces
    • Instruments Markets
    • Table 62 Global Value Of Instruments And Assays Utilizing Biologic Imaging Reagents, Through 2013 ($ Millions)
    • Biologic Imaging Reagents Markets
    • Market Overview
    • Table 63 Global Value Of Biologic Imaging Reagents, By Technology, Through 2013 ($ Millions)
    • Table 64 Global Value Of Biologic Imaging Reagents Market, By End Use, Through 2013 ($ Millions)
    • Table 65 Global Value Of Biologic Reagents Market, By Function, Through 2013 ($ Millions)
    • Table 66 Global Value Of Biologic Imaging Reagents, By End User Market, Through 2013 ($ Millions)
    • Table 67 Global Value Of Biologic Reagents Market, By Modality, Through 2013 ($ Millions)
    • Fluorescent Proteins
    • Table 68 Global Value Of Fluorescent Protein Reagents, By Type, Through 2013 ($ Millions)
    • Nanoparticles
    • Table 69 Global Value Of Imaging Nanoparticles By Technology Through 2013 ($ Millions)
    • Contrast Reagents
    • Table 70 Global Value Of Contrast Agents Market, By Modality, Through 2013 ($ Millions)
    • Table 71 Global Value Of Mri Reagents Market, By Type, Through 2013 ($ Millions)
    • Table 72 Global Value Of Mri Gd Chelate Reagents, By Product, Through 2013 ($ Millions)
    • Nephrogenic Systemic Fibrosis Impact On Gd-Based
    • Contrast Agents
    • Table 73 Global Value Of Mri Non-Gd Chelate Reagents, By Product, Through 2013 ($ Millions)
    • Table 74 Global Sales Of Mri Contrast Reagents, By Procedure, Through 2013 ($ Millions)
    • Table 75 Global Value Of Ultrasound Reagents Market, By Type, Through 2013 ($ Millions)
    • Table 76 Global Value Of X-Ray/Ct Reagents Market, By Type, Through 2013 ($ Millions)
    • Radiopharmaceuticals
    • Table 77 Global Value Of Radiopharmaceuticals Imaging Reagents Market, By Indication, Through 2013 ($ Millions)
    • Table 78 Global Value Of Oncology Radiopharmaceuticals Imaging Reagents Market, By Indication, Through 2013 ($ Millions)
    • Table 79 Global Value Of Oncology Radiopharmaceuticals Imaging Reagents Market, By Product, Through 2013 ($ Millions)
    • Table 80 Global Value Of Fdg Radiopharmaceutical Reagents, By Disease Class, Through 2013 ($ Millions) Optical Imaging Reagents
    • Table 81 Global Value Of Optical Fluorescent Imaging Reagents Market, By Application, Through 2013 ($ Millions)
    • Table 82 Global Value Of In-Vitro Research And Drug Discovery And Development Optical Fluorescent Imaging Reagents Market, By Assay, Through 2013 ($ Millions)
    • Table 83 Global Value Of Genomics In-Vitro Optical Fluorescent Imaging Reagents Market, By Assay Type, Through 2013 ($ Millions)
    • Table 84 Global Value Of Proteomics In-Vitro Optical Fluorescent Imaging Reagents Market, By Assay Type, Through 2013 ($ Millions)
    • Table 85 Global Value Of Cellular Analysis In-Vitro Optical Fluorescent Imaging Reagents Market, By Assay Type, Through 2013 ($ Millions)
    • Table 86 Global Value Of Optical Fluorescent Imaging Reagents, By End Use, Through 2013 ($ Millions)
    • Table 87 Global Value Of In-Vitro Diagnostic Fluorescent Optical Imaging Reagents, By Market Segment, Through 2013 ($ Millions)
    • Table 88 Global Value Of Optical Imaging Reagents, By Type, Through 2013 ($ Millions) Geographical
    • Table 89 Global Value Of Biologic Imaging Reagents, By Geography, Through 2013 ($ Millions)
  • Chapter Eight: Patent Status
    • Imaging Reagents Patents By Selected Technology
    • Table 90 Number Of Patents By Technology Fluorescence Reagents
    • Table 91 Fluorescence Reagents Patent Assignees By Company (Number Of Patents)
    • Fluorescent Proteins
    • Table 92 Fluorescent Protein Patent Assignees By Company (Number Of Patents)
    • Dendrimers
    • Table 93 Dendrimer Patent Assignees By Company (Number Of Patents)
    • Table 94 Quantum Dots Patent Assignees By Company (Number Of Patents) Patents By Company
    • Figure 8 Patents By Company For Market Segments
    • Litigation Status
    • Table 95 Ip Litigation Status
  • Chapter Nine: Company Profiles
    • Acusphere, Inc
    • Table 96 Acusphere Product Pipeline
    • Table 97 Acusphere Patent Estate
    • Table 97 (Continued)
    • Advanced Research Technologies Inc
    • Affibody Ab
    • Aion Diagnostics
    • Alnis Biosciences Inc
    • Alseres Pharmaceuticals Inc
    • Amag Pharmaceuticals
    • Table 98 Amag Molecular Imaging Reagents Pipeline
    • Table 99 Amag Mri Imaging Reagents Marketing
    • Alliances
    • Anticancer Inc
    • Avid Radiopharmaceuticals
    • Table 100 Avid Diagnostic Imaging Pipeline
    • Bayer Schering Pharma Ag
    • Bbi International
    • Bd Biosciences
    • Beckman Coulter, Inc
    • Bioforce Nanosciences Holdings, Inc
    • Biomoda Inc
    • Biophan Technologies, Inc
    • Biosearch Technologies, Inc
    • Biosceptre
    • Biotage Ab
    • Bracco Diagnostics Inc
    • Caliper Life Sciences, Inc
    • Cambridge Isotope Laboratories, Inc
    • Capsulution Nanosciences Ag
    • Cardinal Health
    • Carestream Health, Inc
    • Cellcyte Genetics
    • Chemicell Gmbh
    • China Medical Technologies, Inc
    • Covidien
    • Dendritech, Inc
    • Do-Coop Technologies
    • Ebioscience, Inc
    • Epix Pharmaceuticals
    • Evident Technologies
    • Evrogen
    • Ferropharm Gmbh
    • Fluoropharma
    • Table 101 Fluorpharma Pet Imaging Reagent Pipeline
    • Fluorotechnics Pty Ltd
    • Ge Healthcare
    • Table 102 Ge Healthcare Imaging Reagents Pipeline
    • Guerbet
    • Iba Molecular
    • Immunicon
    • Indec Biosystems
    • Invitrogen
    • Jubilant Organosys Ltd
    • Table 103 Jubilant Organosys Medical Imaging Reagent
    • Pipeline
    • Kereos, Inc
    • Table 104 Kereos Imaging Reagents Pipeline
    • Table 105 Kereos Strategic Alliances
    • Kpl, Inc
    • Lantheus Medical Imaging
    • Table 106 Lantheus Diagnostic Imaging Pipeline
    • Luna Nanoworks
    • Marinpharm Gmbh
    • Mbl International
    • Molecular Insight Pharmaceuticals
    • Molecular Targeting Technologies, Inc
    • Table 107 Mtti Imaging Reagents Pipeline
    • Nanoco Technologies Ltd
    • Nanoprobes, Inc
    • Nanospectra Biosciences
    • Nanosphere, Inc
    • Table 108 Nanosphere Gold Imaging Reagents Pipeline
    • Oxonica Inc
    • Philips Healthcare
    • Promega Corporation
    • Selah Technologies, Llc
    • Siemens Ag
    • Signalomics Gmbh
    • Starpharma Holdings Ltd
    • Takara Bio Inc
    • Thermo Fisher Scientific
    • Tk Signal
    • Visen Medical Inc
    • Wilex Ag
    • Table 109 Wilex Product Pipeline
  • List Of Summary Table
    • Global Value Of Biologic Imaging Reagents, By Type, Through 2013 ($ Millions)
    • Table 1 Scope Of This Report
    • Table 2 Global Value Of Biologic Imaging Reagents, By Technology, Through 2013 ($ Millions)
    • Table 3 Global Value Of Biologic Imaging Reagents, By End User Market, Through 2013 ($ Millions)
    • Table 4 Biologic Imaging Reagents Growth Driving Forces
    • Table 5 Life Cycle Stage Of Biologic Imaging Reagents
    • Table 6 Biologic Imaging Reagents Key Competitors
    • Table 7 Key Biologic Imaging Reagent Types
    • Table 8 In-Vivo Imaging Modalities
    • Table 9 Comparison Of In-Vivo Imaging Modalities
    • Table 10 Applications Of In-Vitro Biologic Imaging
    • Table 11 Key Trends For In-Vivo Imaging
    • Table 12 Nanoparticles In Imaging Applications
    • Table 13 Comparison Of Antibody Conjugate Nanoparticles
    • Table 14 Fluorescent Dyes And Probes
    • Table 15 Advantages Of Fluorescence Versus Traditional Methods
    • Table 16 Fluorescent Dye Performance Criteria
    • Table 17 Types Of Fluorescent Proteins
    • Table 18 Photoactivable And Photoconvertible Fluorescent Protein Types
    • Table 19 Emerging Applications Of Fluorescent Proteins
    • Table 20 Fluorescent Proteins Versus Dyes
    • Table 21 Technology Challenges For Fluorescent Proteins
    • Table 22 Classification Of Imaging Supermolecules
    • Table 23 Comparison Of Quantum Dots, Fluorescent Dyes And Fluorescent Proteins
    • Table 24 Biologic Imaging Applications Of Quantum Dots
    • Table 25 Emerging Advanced Biologic Imaging Reagent Functions
    • Table 26 Life Cycle Of Biologic Imaging Reagent Technologies
    • Table 27 Technology Status Of Biologic Imaging Reagent Platforms
    • Table 28 Technology Challenges For In-Vivo Imaging Reagents
    • Table 29 Biologic Imaging Reagents Applications
    • Table 30 Significance Of Biologic Imaging Reagents To Life Sciences And Medical Industries
    • Table 31 Use Of Biologic Imaging Reagents By Market Segment
    • Table 32 Applications Within Market Segments
    • Table 33 R&d Tools
    • Table 34 Emerging Applications For Biologic Imaging Reagents In R&d Tools
    • Table 35 Drug Discovery & Development
    • Table 36 Comparison Of Small Animal Imaging Modalities
    • Table 37 Outstanding Market Needs For Small Animal Imaging
    • Table 38 Biomarkers For Microdosing
    • Table 39 Microdosing Imaging Modalities
    • Table 40 Diagnostics Imaging Reagents Applications
    • Table 41 Diagnostic Applications Of Selected Imaging Reagents
    • Table 42 Clinical Applications For In Vivo Molecular Imaging
    • Table 43 Fluorescence Imaging Reagents Pipeline Status
    • Table 44 Pet/Spect Imaging Reagents Pipeline Status
    • Table 45 Pet Imaging Reagent Applications
    • Table 46 Existing And Emerging Mri Imaging Reagents Status
    • Table 47 Nanoparticle In-Vivo Diagnostics Pipeline
    • Table 48 Nanosphere In-Vitro Diagnostics Reagents Pipeline
    • Table 49 Hybrid Imaging/Therapeutic Applications
    • Table 50 Competitive Focus Of Major Medical Imaging Companies
    • Table 51 Recent Imaging Reagent Strategic Alliances
    • Table 52 Biologic Imaging Reagents Industry Acquisitions, 2005-2008
    • Table 53 Fluorescent Dyes And Probes Key Competitors
    • Table 54 Quantum Dots Key Competitors
    • Table 55 Contrast Reagents Key Competitors
    • Table 56 Radiopharmaceuticals Biotechnology Companies
    • Table 57 Small Animal In-Vivo Functional Imaging Competitors
    • Table 58 Cardiac Imaging Reagent Competitive Space
    • Table 59 Fluorescent Protein Producers
    • Table 60 Antibody Biotechnology Companies Who Have Interest In Imaging Reagents
    • Table 61 Biologic Imaging Reagents Growth Driving Forces
    • Table 62 Global Value Of Instruments And Assays Utilizing Biologic Imaging Reagents, Through 2013 ($ Millions)
    • Table 63 Global Value Of Biologic Imaging Reagents, By Technology, Through 2013 ($ Millions)
    • Table 64 Global Value Of Biologic Imaging Reagents Market, By End Use, Through 2013 ($ Millions)
    • Table 65 Global Value Of Biologic Reagents Market, By Function, Through 2013 ($ Millions)
    • Table 66 Global Value Of Biologic Imaging Reagents, By End User Market, Through 2013 ($ Millions)
    • Table 67 Global Value Of Biologic Reagents Market, By Modality, Through 2013 ($ Millions)
    • Table 68 Global Value Of Fluorescent Protein Reagents, By Type, Through 2013 ($ Millions)
    • Table 69 Global Value Of Imaging Nanoparticles By Technology Through 2013 ($ Millions)
    • Table 70 Global Value Of Contrast Agents Market, By Modality, Through 2013 ($ Millions)
    • Table 71 Global Value Of Mri Reagents Market, By Type, Through 2013 ($ Millions)
    • Table 72 Global Value Of Mri Gd Chelate Reagents, By Product, Through 2013 ($ Millions)
    • Table 73 Global Value Of Mri Non-Gd Chelate Reagents, By Product, Through 2013 ($ Millions)
    • Table 74 Global Sales Of Mri Contrast Reagents, By Procedure, Through 2013 ($ Millions)
    • Table 75 Global Value Of Ultrasound Reagents Market, By Type, Through 2013 ($ Millions)
    • Table 76 Global Value Of X-Ray/Ct Reagents Market, By Type, Through 2013 ($ Millions)
    • Table 77 Global Value Of Radiopharmaceuticals Imaging Reagents Market, By Indication, Through 2013 ($ Millions)
    • Table 78 Global Value Of Oncology Radiopharmaceuticals Imaging Reagents Market, By Indication, Through 2013 ($ Millions)
    • Table 79 Global Value Of Oncology Radiopharmaceuticals Imaging Reagents Market, By Product, Through 2013 ($ Millions)
    • Table 80 Global Value Of Fdg Radiopharmaceutical Reagents, By Disease Class, Through 2013 ($ Millions)
    • Table 81 Global Value Of Optical Fluorescent Imaging Reagents Market, By Application, Through 2013 ($ Millions)
    • Table 82 Global Value Of In-Vitro Research And Drug Discovery And Development Optical Fluorescent Imaging Reagents Market, By Assay, Through 2013 ($ Millions)
    • Table 83 Global Value Of Genomics In-Vitro Optical Fluorescent Imaging Reagents Market, By Assay Type, Through 2013 ($ Millions)
    • Table 84 Global Value Of Proteomics In-Vitro Optical Fluorescent Imaging Reagents Market, By Assay Type, Through 2013 ($ Millions)
    • Table 85 Global Value Of Cellular Analysis In-Vitro Optical Fluorescent Imaging Reagents Market, By Assay Type, Through 2013 ($ Millions)
    • Table 86 Global Value Of Optical Fluorescent Imaging Reagents, By End Use, Through 2013 ($ Millions)
    • Table 87 Global Value Of In-Vitro Diagnostic Fluorescent Optical Imaging Reagents, By Market Segment, Through 2013 ($ Millions)
    • Table 88 Global Value Of Optical Imaging Reagents, By Type, Through 2013 ($ Millions)
    • Table 89 Global Value Of Biologic Imaging Reagents, By Geography, Through 2013 ($ Millions)
    • Table 90 Number Of Patents By Technology
    • Table 91 Fluorescence Reagents Patent Assignees By Company (Number Of Patents)
    • Table 92 Fluorescent Protein Patent Assignees By Company (Number Of Patents)
    • Table 93 Dendrimer Patent Assignees By Company (Number Of Patents)
    • Table 94 Quantum Dots Patent Assignees By Company (Number Of Patents)
    • Table 95 Ip Litigation Status
    • Table 96 Acusphere Product Pipeline
    • Table 97 Acusphere Patent Estate
    • Table 98 Amag Molecular Imaging Reagents Pipeline
    • Table 99 Amag Mri Imaging Reagents Marketing Alliances
    • Table 100 Avid Diagnostic Imaging Pipeline
    • Table 101 Fluorpharma Pet Imaging Reagent Pipeline
    • Table 102 Ge Healthcare Imaging Reagents Pipeline
    • Table 103 Jubilant Organosys Medical Imaging Reagent Pipeline
    • Table 104 Kereos Imaging Reagents Pipeline
    • Table 105 Kereos Strategic Alliances
    • Table 106 Lantheus Diagnostic Imaging Pipeline
    • Table 107 Mtti Imaging Reagents Pipeline
    • Table 108 Nanosphere Gold Imaging Reagents Pipeline
    • Table 109 Wilex Product Pipeline
  • List Of Figures
    • Summary Figure Global Value Of Biologic Imaging Reagents, By Type, 2006-2013 ($ Millions)
    • Figure 1 Molecular Engineering Of Dendrimer Imaging Supermolecules
    • Figure 2 Quantum Dot Spectra
    • Figure 3 Fluorescent Dye Spectra
    • Figure 4 Three Components Of Advanced Imaging Reagent Technology
    • Figure 5 Manufacturing Costs Of Imaging Reagent Classes
    • Figure 6 Attrition Rate Of Drug Candidates During Drug Development
    • Figure 7 Alzheimer's Disease's Pathology Progression
    • Figure 8 Patents By Company For Market Segments